[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JPS5488249A - 22adamantylhydrazine derivatives or their acid added salts - Google Patents

22adamantylhydrazine derivatives or their acid added salts

Info

Publication number
JPS5488249A
JPS5488249A JP14492778A JP14492778A JPS5488249A JP S5488249 A JPS5488249 A JP S5488249A JP 14492778 A JP14492778 A JP 14492778A JP 14492778 A JP14492778 A JP 14492778A JP S5488249 A JPS5488249 A JP S5488249A
Authority
JP
Japan
Prior art keywords
derivatives
acid added
added salts
salts
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP14492778A
Other languages
English (en)
Inventor
Beineru Bennjion
Suteruringu Jiefurei
Suchi Rauru
Ierin Haimu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceutical Industries Ltd
Original Assignee
Teva Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd filed Critical Teva Pharmaceutical Industries Ltd
Publication of JPS5488249A publication Critical patent/JPS5488249A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/76Nitrogen atoms to which a second hetero atom is attached
    • C07D213/77Hydrazine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/80Two oxygen atoms, e.g. hydantoin with hetero atoms or acyl radicals directly attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/28Nitrogen atoms
    • C07D295/30Nitrogen atoms non-acylated

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP14492778A 1977-11-22 1978-11-21 22adamantylhydrazine derivatives or their acid added salts Pending JPS5488249A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL53440A IL53440A0 (en) 1977-11-22 1977-11-22 2-adamantyl hydrazines their preparation and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
JPS5488249A true JPS5488249A (en) 1979-07-13

Family

ID=11049917

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14492778A Pending JPS5488249A (en) 1977-11-22 1978-11-21 22adamantylhydrazine derivatives or their acid added salts

Country Status (9)

Country Link
US (1) US4254128A (ja)
EP (1) EP0002066B1 (ja)
JP (1) JPS5488249A (ja)
AU (1) AU4184378A (ja)
CA (1) CA1119170A (ja)
DE (1) DE2862274D1 (ja)
IL (1) IL53440A0 (ja)
IT (1) IT1101419B (ja)
ZA (1) ZA786543B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683311A (en) * 1986-01-22 1987-07-28 Pennwalt Corporation Spiro[isoxazalidine-3,2'-tricyclo[3.3.1.13,7 ] decanes]
US5488035A (en) * 1991-12-06 1996-01-30 Pioneer Hi-Bred International, Inc. Peptide with inhibitory activity towards plant pathogenic fungi
US5977360A (en) * 1996-12-27 1999-11-02 Japan Hydrazine Co., Ltd. Process for producing cyclic hydrazine derivatives, tetra-hydropyridazine and hexahydropyridazine
US6429207B1 (en) 1997-11-21 2002-08-06 Nps Pharmaceuticals, Inc. Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
WO1999026927A2 (en) * 1997-11-21 1999-06-03 Nps Pharmaceuticals, Inc. Metabotropic glutamate receptor antagonists for treating central nervous system diseases
WO2009132101A1 (en) * 2008-04-22 2009-10-29 Northeastern University Methods of treating fungal infections

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054275A (ja) * 1963-05-01
US3328251A (en) * 1965-12-30 1967-06-27 Du Pont Pharmaceutical compositions and methods utilizing 2-aminoadamantane and its derivatives
AT274779B (de) * 1966-09-09 1969-09-25 Bayer Ag Verfahren zur Herstellung von neuen 1-Hydrazinoadamantanen
US4100170A (en) * 1967-12-18 1978-07-11 Pennwalt Corporation Anorectic adamantane derivatives and method of using the same
US3703537A (en) * 1969-10-28 1972-11-21 Cilag Chemie Adamantyl urea derivatives
US3838151A (en) * 1972-08-11 1974-09-24 Richardson Merrell Inc Cycloalkyllactamimides
US4061774A (en) * 1974-03-02 1977-12-06 Lilly Industries, Limited Halogenated amino methyl adamantane derivatives

Also Published As

Publication number Publication date
EP0002066A1 (en) 1979-05-30
ZA786543B (en) 1979-10-31
IL53440A0 (en) 1978-01-31
EP0002066B1 (en) 1983-05-25
IT1101419B (it) 1985-09-28
US4254128A (en) 1981-03-03
AU4184378A (en) 1979-05-31
IT7830071A0 (it) 1978-11-22
DE2862274D1 (en) 1983-07-07
CA1119170A (en) 1982-03-02

Similar Documents

Publication Publication Date Title
IL56099A0 (en) Phthalazin-4-ylacetic acid derivatives
ZA783719B (en) Pyridyloxy-phenoxyalkanecarboxylic acid derivatives
PT71744B (en) Substituted beta-carbolin-3-carboxylic acid derivatives
PH15764A (en) Cephalosporanic acid derivatives
GB2002762B (en) Cycloalkylidenemethylphenylacetic acid derivatives
GB2005264B (en) Haloaminoalkanoic acid derivatives
GB2117774B (en) Oximinoacetic acid derivatives
GB1557553A (en) Oxazolinoazetidinylbutyric acid derivatives
JPS5488249A (en) 22adamantylhydrazine derivatives or their acid added salts
GB2075968B (en) Benzylsulphonic acid derivatives
AU4057878A (en) Clavulinic acid derivatives
GB2005251B (en) Isophthalic acid derivatives
AU3315778A (en) Benzoheterocyclylglyoxylic acid derivatives
GB2053912B (en) Acylaminobenzoic acid derivatives
AU3692878A (en) Piperazine carbodithioic acid derivatives
NZ189245A (en) Substituted 2-(2-amino-4-thiazoyl)-2-hydroxyimino-acetic acid derivatives
NZ187541A (en) 2-acetylene-2-amino-3-phenylpropionic acid derivatives
AU4248378A (en) Phosphonic acid derivatives
JPS5473794A (en) 22diphenylmethyleneindolithidine tertial salt derivatives
JPS5444661A (en) Oxanilic acid derivative
GB1554118A (en) 2-oxo-3-phenylbutanoic acid derivatives
ZA783883B (en) Phenoxyphenylthioalkanecarboxylic acid derivatives
GB2125035B (en) 6b-halopenicillanic acid derivatives
GB2051781B (en) Oxoamino acid derivatives
ZA78437B (en) Acid derivatives